The first CDC42 variant (p.Arg68Gln) associated with Takenouchi-Kosaki syndrome in Asia: a case report and literature review

The Big Picture: A Broken Switch in the Body's Construction Crew

Imagine your body is a massive construction site building a human being. To do this correctly, you need a foreman who tells the workers when to start, stop, move, and build specific parts like the brain, the face, and the blood. In this story, that foreman is a protein called CDC42.

CDC42 works like a smart light switch. It has two positions: ON (active) and OFF (inactive). It flips back and forth rapidly to tell cells exactly what to do. If the switch gets stuck or broken, the construction crew gets confused. Some parts get built too big, some too small, and some don't get built at all.

This specific case report is about a young girl in Asia who has a broken "switch" in her CDC42 gene. This condition is called Takenouchi-Kosaki Syndrome (TKS). While this syndrome has been seen in other parts of the world, this is the first time it has been documented in an Asian child with this specific type of broken switch.

The Patient's Story: A Girl with a Unique Blueprint

The patient is an 11-year-old girl. When she was born, she was smaller than average, and doctors noticed she had a hole in her heart (a common issue when the construction site is confused) and was born deaf.

As she grew up, several things became clear:

• She didn't grow tall: At 11, she was much shorter than her peers (like a sapling that hasn't reached the sunlight).
• Her face looked different: She had wide-set eyes, a flat nose bridge, and a small chin. Think of it as the "architectural plans" for her face were slightly off-center.
• Her hands were unique: Her fingers were thin, and her pinky fingers curled inward (a condition called camptodactyly).
• Her blood was tricky: She had low platelets. If platelets are the "band-aids" your body uses to stop bleeding, she had fewer band-aids than usual, though she wasn't bleeding spontaneously.
• Her brain developed slowly: She learned to walk and talk later than other children and struggled in school.

The Detective Work: Finding the Glitch

Doctors wanted to know why this was happening. They ran a genetic test (like checking the master blueprint) and found a tiny typo in the CDC42 gene.

• The Specific Error: The gene had a change at a very specific spot, turning a building block called "Arginine" into "Glutamine" at position 68. In the paper, this is written as p.Arg68Gln.
• Why it matters: This specific typo breaks the "Switch II" part of the CDC42 foreman. It's like someone put a piece of gum on the light switch so it can't click properly. Because of this, the cells can't communicate well, leading to the problems with her growth, face, hearing, and blood.
• It was new to her: The doctors checked her parents' genes, and neither of them had this typo. It was a "de novo" mutation, meaning it happened spontaneously in the egg or sperm that created her. It wasn't inherited from her family.

Note: The girl also had a second, separate genetic issue in a different gene (GJB2) that contributed to her deafness. It's like she had two different typos in her blueprints, both affecting her hearing.

What the Paper Found: Connecting the Dots

The researchers compared this girl to only two other people in the entire world who have this exact same broken switch (Arg68Gln).

1. The Pattern: All three patients (the two from before and this new girl) looked very similar. They all had:

   • Short stature.
   • Distinctive facial features.
   • Low platelets.
   • Hearing loss.
   • Developmental delays.

2. The "Extra" Problems: The other two patients had some scary, complex issues like heart muscle problems, lung issues, or severe inflammation. This girl didn't have those severe complications yet, but the paper warns that because the "foreman" is broken, she needs to be watched closely for these potential issues in the future.

The Treatment: Trying to Help the Construction

The girl's biggest worry was her height. She was very short, which made her feel anxious and self-conscious.

• The Experiment: There are no official rules for treating short stature caused by this specific broken switch. However, doctors know that a similar broken switch (in a different gene) responds well to Growth Hormone.
• The Logic: Since the CDC42 gene and that other gene both use the same "communication highway" (the MAPK pathway) to tell bones to grow, the doctors decided to try giving her Recombinant Human Growth Hormone (rhGH).
• The Goal: This is an "off-label" use, meaning they are using the medicine for a purpose it wasn't originally approved for, just to see if it helps. They are monitoring her closely to see if she grows taller and if the medicine is safe for her specific condition.

The Bottom Line

This paper is important because:

1. It fills a gap: It proves that this specific genetic "broken switch" exists in Asian populations, not just in the West.
2. It defines the symptoms: It confirms that people with this specific mutation share a very predictable set of symptoms (short, specific face, low platelets, hearing loss).
3. It offers hope: It shows that doctors are trying new, targeted treatments (like growth hormone) to help these children, even when there are no perfect guidelines yet.

In short, this is a story about finding a specific broken part in a child's genetic blueprint, understanding how that break causes a specific set of problems, and carefully trying a new tool to help her grow and thrive.